Pharma News Intelligence February 14, 2024
US Senate HELP Committee’s 2024 report exposes J&J, Merck, and BMS for prioritizing profits over Americans’ well-being with exorbitant drug prices.
On February 6, 2024, the United States Senate’s Health, Education, Labor, and Pensions (HELP) Committee published a Majority Staff Report highlighting the issue of exorbitant drug prices in the United States. It focuses on the business practices of three major pharmaceutical companies — Johnson & Johnson (J&J), Merck, and Bristol Myers Squibb (BMS). The report reveals how these companies have prioritized profits over the well-being of the American people by charging excessively high prices for prescription drugs.
Key Findings
In 2022, the pharmaceutical industry’s top players, including J&J, Merck, and BMS, amassed a staggering profit, underscoring concerns about prioritizing...
Today's Sponsors
Today's Sponsor